Epigenetic Regulation of BDNF Gene during Development and Diseases
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Brain-derived neurotrophic factor (BDNF) is required for the development of the nervous system, proper cognitive function and memory formation. While aberrant expression of BDNF has been implicated in neurological disorders, the transcriptional regulation of BDNF remains to be elucidated. In response to different stimuli, BDNF expression can be initiated from different promoters. Several studies have suggested that the expression of BDNF is regulated by promoter methylation. An emerging theme points to the possibility that histone modifications at the BDNF promoters may link to the neurological pathology. Thus, understanding the epigenetic regulation at the BDNF promoters will shed light on future therapies for neurological disorders. The present review summarizes the current knowledge of histone modifications of the BDNF gene in neuronal diseases, as well as the developmental regulation of the BDNF gene based on data from the Encyclopedia of DNA Elements (ENCODE).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“this leads to the upregulation of hippocampal AMPAR subunits GluA1 and GluA2, and the activation of tropomyosin receptor kinase B (TrkB), which triggers intracellular pathways that contribute to synaptogenesis and the enhancement of NMDA receptor activity.”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [49]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“BDNF then activates TrkB receptors on postsynaptic neurons and increases surface expression of the hippocampal AMPA receptor subunits GluA1 and GluA2, which are necessary for the synaptic and behavioral effects of ketamine [49,52,59,60].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [49]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072 · cited 5×
“The ENCODE database provides a user-friendly platform that allows readers to visualize data using the University of California Santa Cruz (UCSC, Sa a Cruz, CA, USA) genome browser and making comparisons am ng different experiments [22].”
MethodInfluentialChromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping
Rao, S. S. P., Huntley, M. H., Durand, N. C., Stamenova, E. K., Bochkov, I. D., Robinson, J. T., Sanborn, A. L., Machol, I., Omer, A. D., Lander, E. S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.021 · Cited by 9,212 · cited 3×
“The physical association between promoter and enhancer was found through a CCCTC-binding factor (CTCF) [39,40].”
BackgroundA bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361 · cited 1×
“Interestingly, these regions were enriched with both H3K27me3 and H3K4me3, indicating a bivalent chromatin mark (Figure 2C,D) [32].”
BackgroundHistone H3K27ac separates active from poised enhancers and predicts developmental state
Creyghton, M. P., Cheng, A. W., Welstead, G. G., Kooistra, T., Carey, B. W., Steine, E. J., Hanna, J., Lodato, M. A., Frampton, G. M., Sharp, P. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016071107 · Cited by 4,302 · cited 1×
“Histone H3 lysine 4 mono-methylation (H3K4me1) and histone H3 lysine 27 acetylation (H3K27ac) mark the active enhancer region of genes leading to the increase of gene expression [26,27].”
BackgroundA unique chromatin signature uncovers early developmental enhancers in humans
Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S. A., Flynn, R. A., & Wysocka, J. (2011) · Nature · doi:10.1038/nature09692 · Cited by 2,233 · cited 2×
“On one hand, the combination of H3K4me1 and histone H3 lysine 27 tri-methylation (H3K27me3) indicates a poised enhancer region [28].”
BackgroundDNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405 · cited 1×
“Another report showed that elevation of H3K4me2, H3K14ac and H4ac with concomitant decline of H3K9me2 and HDAC1 was observed in Bdnf promoter VI upon KCl stimulation [43].”
BackgroundDerepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232 · cited 1×
“Depolarization of neurons by KCl increases H3K9ac, but decreases H3K9me2 at Bdnf promoter IV [42].”
BackgroundArchitectural protein subclasses shape 3D organization of genomes during lineage commitment
Phillips-Cremins, J. E., Sauria, M. E. G., Sanyal, A., Gerasimova, T. I., Lajoie, B. R., Bell, J. S. K., Ong, C.-T., Hookway, T. A., Guo, C., Sun, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.053 · Cited by 1,187 · cited 3×
“The physical association between promoter and enhancer was found through a CCCTC-binding factor (CTCF) [39,40].”
BackgroundLoss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,123 · cited 1×
“The expression of mutated Huntington’s in vitro and in vivo down-regulates Bdnf expression [49].”
BackgroundShilatifard, A. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142422 · Cited by 1,103 · cited 1×
“However, no H3K36me3 mark was enriched in this region, which is consistent with other studies in which H3K36me3 usually marks the active genes [31] (Figure 2E).”
ResultJones, K. R., Fariñas, I., Backus, C., & Reichardt, L. F. (1994) · Cell · doi:10.1016/0092-8674(94)90377-8 · Cited by 1,042
REST and Its Corepressors Mediate Plasticity of Neuronal Gene Chromatin throughout Neurogenesis
Ballas, N., Grunseich, C., Lu, D. D., Speh, J. C., & Mandel, G. (2005) · Cell · doi:10.1016/j.cell.2005.03.013 · Cited by 950
Mouse and rat BDNF gene structure and expression revisited
Aid, T., Kazantseva, A., Piirsoo, M., Palm, K., & Timmusk, T. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21139 · Cited by 943 · cited 3×
“Kainic acid, a glutamate analogue, induced transcription of Bdnf exons I, IV, V VII, VIII and IXA in rat hippocampus while N-methyl-D-aspartate (NMDA) treatment identified Bdnf exons II and IV, but not I and III, as fast-reacting exons [15,35].”
BackgroundBDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
Phillips, H. S., Hains, J. M., Armanini, M., Laramee, G. R., Johnson, S. A., & Winslow, J. W. (1991) · Neuron · doi:10.1016/0896-6273(91)90273-3 · Cited by 921 · cited 1×
“In the brain of AD patients, the reduction of BDNF expression was observed in several independent studies [62,63].”
ResultLateral Thinking: How Histone Modifications Regulate Gene Expression
Lawrence, M., Daujat, S., & Schneider, R. (2016) · Trends in Genetics · doi:10.1016/j.tig.2015.10.007 · Cited by 908 · cited 1×
“These histones are post-translationally modified by methylation, acetylation, phosphorylation, ubiquitination, sumoylation and other modifications [25].”
BackgroundPotential therapeutic uses of BDNF in neurological and psychiatric disorders
Nagahara, A. H., & Tuszynski, M. H. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3366 · Cited by 867 · cited 2×
“Furthermore, the addition of a BDNF protein or elevation of BDNF by the Bdnf gene (human gene: BDNF; mouse gene: Bndf ) delivery in animal models of neurological and psychiatric disorders improves memory formation and the survival of neuronal cells [14].”
BackgroundENCODE Data in the UCSC Genome Browser: year 5 update
Rosenbloom, K. R., Sloan, C. A., Malladi, V. S., Dreszer, T. R., Learned, K., Kirkup, V. M., Wong, M. C., Maddren, M., Fang, R., Heitner, S. G., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1172 · Cited by 766 · cited 2×
“The ENCODE database provides a user-friendly platform that allows readers to visualize data using the University of California Santa Cruz (UCSC, Santa Cruz, CA, USA) genome browser and making comparisons among different experiments [22].”
MethodPruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.004 · Cited by 699
Lindsay, R. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-07-02394.1988 · Cited by 662
A Genetic Variant BDNF Polymorphism Alters Extinction Learning in Both Mouse and Human
Soliman, F., Glatt, C. E., Bath, K. G., Levita, L., Jones, R. M., Pattwell, S. S., Jing, D., Tottenham, N., Amso, D., Somerville, L. H., et al. (2010) · Science · doi:10.1126/science.1181886 · Cited by 585
Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions
Zentner, G. E., Tesar, P. J., & Scacheri, P. C. (2011) · Genome Research · doi:10.1101/gr.122382.111 · Cited by 564 · cited 1×
“Histone H3 lysine 4 mono-methylation (H3K4me1) and histone H3 lysine 27 acetylation (H3K27ac) mark the active enhancer region of genes leading to the increase of gene expression [26,27].”
BackgroundCorepressor-Dependent Silencing of Chromosomal Regions Encoding Neuronal Genes
Lunyak, V. V., Burgess, R., Prefontaine, G. G., Nelson, C., Sze, S.-H., Chenoweth, J., Schwartz, P., Pevzner, P. A., Glass, C., Mandel, G., et al. (2002) · Science · doi:10.1126/science.1076469 · Cited by 472
Spatial Distribution of Di- and Tri-methyl Lysine 36 of Histone H3 at Active Genes
Bannister, A. J., Schneider, R., Myers, F. A., Thorne, A. W., Crane-Robinson, C., & Kouzarides, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500796200 · Cited by 459 · cited 2×
“repressive promoter whereas histone H3 lysine 36 tri-methylation (H3K36me3) marks the gene body in general, which can indicate either active or repressive transcription [29,30].”
BackgroundAkbarian, S., Liu, C., Knowles, J. A., Vaccarino, F. M., Farnham, P. J., Crawford, G. E., Jaffe, A. E., Pinto, D., Dracheva, S., Geschwind, D. H., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4156 · Cited by 451 · cited 2×
“In addition, a similar project, PsychENCODE, was initiated in 2015 [23] and aims to decode the gene expressions and their regulatory domain, as does as ENCODE project, but focuses on human brain diseases.”
MethodSchwartz, P. M., Borghesani, P. R., Levy, R. L., Pomeroy, S. L., & Segal, R. A. (1997) · Neuron · doi:10.1016/s0896-6273(00)80938-1 · Cited by 437
Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes
Huang, Y., Myers, S. J., & Dingledine, R. (1999) · Nature Neuroscience · doi:10.1038/13165 · Cited by 396
Lindsay, R. M., Thoenen, H., & Barde, Y.-A. (1985) · Developmental Biology · doi:10.1016/0012-1606(85)90402-6 · Cited by 380
Visualizing synapse formation in arborizing optic axons in vivo: dynamics and modulation by BDNF
Alsina, B., Vu, T., & Cohen-Cory, S. (2001) · Nature Neuroscience · doi:10.1038/nn735 · Cited by 373
Holsinger, R. M. D., Schnarr, J., Henry, P., Castelo, V. T., & Fahnestock, M. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00023-1 · Cited by 328 · cited 1×
“In the brain of AD patients, the reduction of BDNF expression was observed in several independent studies [62,63].”
ResultRodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine
Liu, Q.-R., Lu, L., Zhu, X.-G., Gong, J.-P., Shaham, Y., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.10.004 · Cited by 297
Zuccato, C., Belyaev, N., Conforti, P., Ooi, L., Tartari, M., Papadimou, E., MacDonald, M., Fossale, E., Zeitlin, S., Buckley, N., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4278-06.2007 · Cited by 288 · cited 1×
“For example, RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) targets the neuron-restrictive silencer element (NRSE) to repress BDNF transcript at promoter II [54].”
BackgroundBDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice
Xie, Y., Hayden, M. R., & Xu, B. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1637-10.2010 · Cited by 236 · cited 1×
“Furthermore, the elevation of Bdnf in the brain of a HD animal model ameliorated HD-associated symptoms [47,48].”
BackgroundThe Co-repressor mSin3A Is a Functional Component of the REST-CoREST Repressor Complex
Grimes, J. A., Nielsen, S. J., Battaglioli, E., Miska, E. A., Speh, J. C., Berry, D. L., Atouf, F., Holdener, B. C., Mandel, G., & Kouzarides, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9461 · Cited by 235
Zuccato, C., Marullo, M., Conforti, P., MacDonald, M. E., Tartari, M., & Cattaneo, E. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00111.x · Cited by 231 · cited 1×
“The expression of BDNF was reduced in the brain of HD patients [46].”
BackgroundNaruse, Y., Aoki, T., Kojima, T., & Mori, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13691 · Cited by 229
Liu, Q., Walther, D., Drgon, T., Polesskaya, O., Lesnick, T. G., Strain, K. J., de Andrade, M., Bower, J. H., Maraganore, D. M., & Uhl, G. R. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30109 · Cited by 226
Roopra, A., Sharling, L., Wood, I. C., Briggs, T., Bachfischer, U., Paquette, A. J., & Buckley, N. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2147-2157.2000 · Cited by 210
Gharami, K., Xie, Y., An, J. J., Tonegawa, S., & Xu, B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05137.x · Cited by 184 · cited 1×
“Furthermore, the elevation of Bdnf in the brain of a HD animal model ameliorated HD-associated symptoms [47,48].”
BackgroundTargeting H3K4 trimethylation in Huntington disease
Vashishtha, M., Ng, C. W., Yildirim, F., Gipson, T. A., Kratter, I. H., Bodai, L., Song, W., Lau, A., Labadorf, A., Vogel-Ciernia, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311323110 · Cited by 177 · cited 2×
“Moreover, Jarid1c, the H3K4me3 demethylase, was dysregulated in the HD mouse model [50].”
BackgroundAmador-Arjona, A., Cimadamore, F., Huang, C.-T., Wright, R., Lewis, S., Gage, F. H., & Terskikh, A. V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421480112 · Cited by 176 · cited 7×
“CTCF ChIP-seq combined with chromosome conformation capture followed by next-generation sequencing (4C-seq) revealed multiple regions around Bdnf promoters I–III as well as V–VII contact with Bdnf promoter IV [41].”
BackgroundInfluentialRichner, M., Ulrichsen, M., Elmegaard, S. L., Dieu, R., Pallesen, L. T., & Vaegter, C. B. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8706-9 · Cited by 161
Ichim, G., Tauszig-Delamasure, S., & Mehlen, P. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.03.006 · Cited by 135
ApoE4 and Aβ Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation
Sen, A., Nelson, T. J., & Alkon, D. L. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0260-15.2015 · Cited by 133 · cited 1×
“Furthermore, compared to healthy controls, a higher level of HDAC6 was found in nucleus in AD patients [66].”
BackgroundZheleznyakova, G. Y., Cao, H., & Schiöth, H. B. (2016) · Behavioral and Brain Functions · doi:10.1186/s12993-016-0101-4 · Cited by 127 · cited 1×
“The regulation of BDNF by DNA methylation and non-coding RNA in neurological diseases has been reviewed in References [44,45].”
BackgroundChantalat, S., Depaux, A., Héry, P., Barral, S., Thuret, J.-Y., Dimitrov, S., & Gérard, M. (2011) · Genome Research · doi:10.1101/gr.118091.110 · Cited by 121 · cited 2×
“repressive promoter whereas histone H3 lysine 36 tri-methylation (H3K36me3) marks the gene body in general, which can indicate either active or repressive transcription [29,30].”
BackgroundKoppel, I., & Timmusk, T. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.015 · Cited by 114 · cited 1×
“The addition of suberoylanilide hydroxamic acid (SAHA), another HDAC class I and II inhibitor, elevates both H3ac and H4ac at Bdnf promoters I and IV in cortical neurons [38].”
BackgroundPalomer, E., Carretero, J., Benvegnù, S., Dotti, C. G., & Martin, M. G. (2016) · Nature Communications · doi:10.1038/ncomms11081 · Cited by 105 · cited 4×
“In both ES cell-derived and adult hippocampal progenitor cells, knockdown of SOX2 increased the H3K27me3 level as well as the occupancy of its methyltransferase, an enhancer of zeste homolog 2 (EZH2) at Bdnf promoter I–III [33].”
BackgroundInfluentialBaj, G., D'Alessandro, V., Musazzi, L., Mallei, A., Sartori, C. R., Sciancalepore, M., Tardito, D., Langone, F., Popoli, M., & Tongiorgi, E. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.5 · Cited by 103 · cited 1×
“In addition, exon VI was increased in hippocampal CA3, but not CA1 and dentate gyrus neurons in response to the antidepressant drugs fluoxetine and reboxetine [34].”
BackgroundSams, D. S., Nardone, S., Getselter, D., Raz, D., Tal, M., Rayi, P. R., Kaphzan, H., Hakim, O., & Elliott, E. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.004 · Cited by 92 · cited 1×
“CTCF ChIP-seq combined with chromosome conformation capture followed by next-generation sequencing (4C-seq) revealed multiple regions around Bdnf promoters I–III as well as V–VII contact with Bdnf promoter IV [41].”
MethodKalcheim, C., & Gendreau, M. (1988) · Developmental Brain Research · doi:10.1016/0165-3806(88)90171-x · Cited by 85
Girardot, M., Hirasawa, R., Kacem, S., Fritsch, L., Pontis, J., Kota, S. K., Filipponi, D., Fabbrizio, E., Sardet, C., Lohmann, F., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt884 · Cited by 85 · cited 1×
“Although PRMT5-mediated H4R3me2s has been shown to silence gene expression, H4R3me2s ChIP-seq data reveal that H4R3me2s locates to both active and inactive genes in ES cells [53].”
BackgroundHendrickx, A., Pierrot, N., Tasiaux, B., Schakman, O., Kienlen‐Campard, P., Smet, C. D., & Octave, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099467 · Cited by 81 · cited 1×
“In an amyloid precursor protein (APP) knockout mouse model—without APP—accumulation of H4ac, but not H3ac or histone H2B acetylation (H2Bac), was observed at Bdnf promoter IV in the prefrontal cortex [65].”
BackgroundRatovitski, T., Arbez, N., Stewart, J. C., Chighladze, E., & Ross, C. A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1033595 · Cited by 74 · cited 1×
“Symmetrical arginine methylation of H2A/H4R3 (H2A/H4R3me2s) mediated by protein arginine methyltransferase 5 (PRMT5) was reduced at the BDNF promoter II in the brain of HD patients [51,52].”
BackgroundBDNF Facilitates L-LTP Maintenance in the Absence of Protein Synthesis through PKMζ
Mei, F., Nagappan, G., Ke, Y., Sacktor, T. C., & Lu, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021568 · Cited by 72
Abidin, I., Eysel, U. T., Lessmann, V., & Mittmann, T. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.148627 · Cited by 69
Aging Triggers a Repressive Chromatin State at Bdnf Promoters in Hippocampal Neurons
Palomer, E., Martín-Segura, A., Baliyan, S., Ahmed, T., Balschun, D., Venero, C., Martin, M. G., & Dotti, C. G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.028 · Cited by 66 · cited 1×
“compared with young mice (8 months) [36].”
Abidin, I., Köhler, T., Weiler, E., Zoidl, G., Eysel, U. T., Lessmann, V., & Mittmann, T. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05242.x · Cited by 60
Tognoli, C., Rossi, F., Di Cola, F., Baj, G., Tongiorgi, E., Terova, G., Saroglia, M., Bernardini, G., & Gornati, R. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-4 · Cited by 58 · cited 1×
“Exons I, II, IV and VI of BDNF between humans and rodents are highly conserved [19].”
BackgroundBaj, G., Del Turco, D., Schlaudraff, J., Torelli, L., Deller, T., & Tongiorgi, E. (2013) · Hippocampus · doi:10.1002/hipo.22100 · Cited by 55 · cited 2×
“promotes the transcription of exons V, VII and VIII of Bdnf in the soma of the CA1 region within the hippocampus [20].”
BackgroundIshimaru, N., Fukuchi, M., Hirai, A., Chiba, Y., Tamura, T., Takahashi, N., Tabuchi, A., Tsuda, M., & Shiraishi, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.139 · Cited by 54 · cited 1×
“For example, treatment of trichostatin A (TSA), a HDAC class I and II inhibitor, increases histone H3 and H4 acetylation (H3ac and H4ac, respectively) at Bdnf promoter I in Neuro-2A cells [37].”
BackgroundMeCP2: a novel Huntingtin interactor
McFarland, K. N., Huizenga, M. N., Darnell, S. B., Sangrey, G. R., Berezovska, O., Cha, J.-H. J., Outeiro, T. F., & Sadri-Vakili, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt499 · Cited by 54
Wilczek, C., Chitta, R., Woo, E., Shabanowitz, J., Chait, B. T., Hunt, D. F., & Shechter, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.303677 · Cited by 54 · cited 1×
“Symmetrical arginine methylation of H2A/H4R3 (H2A/H4R3me2s) mediated by protein arginine methyltransferase 5 (PRMT5) was reduced at the BDNF promoter II in the brain of HD patients [51,52].”
BackgroundEpigenetic suppression of hippocampal BDNF mediates the memory deficiency induced by amyloid fibrils
Wang, B., Zhong, Y., Zhao, Z., & Miao, Y. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.09.009 · Cited by 38 · cited 1×
“Infusion of amyloid fibrils, one possible pathogenic protein, into the hippocampus of rats induces HDAC2 expression, as well as HDAC2 occupancy at promoter VI of Bdnf and thus represses Bdnf expression [64].”
BackgroundTargeting MicroRNAs Involved in the BDNF Signaling Impairment in Neurodegenerative Diseases
You, H. J., Park, J. H., Pareja-Galeano, H., Lucía, A., & Shin, J. I. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8407-9 · Cited by 15 · cited 1×
“The regulation of BDNF by DNA methylation and non-coding RNA in neurological diseases has been reviewed in References [44,45].”
BackgroundConcept and molecular basis of axonal regeneration after central nervous system injury
Muramatsu, R., & Yamashita, T. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.07.002 · Cited by 13
Cited by
Physical Activity and Brain Health
Di Liegro, C. M., Schiera, G., Proia, P., & Di Liegro, I. (2019) · Genes · doi:10.3390/genes10090720 · Cited by 370
“As a result of this gene structure, many species of mature transcripts are known, even if the final translation product is the same for all of them [98,99].”
BackgroundImpact of social relationships on Alzheimer’s memory impairment: mechanistic studies
Hsiao, Y.-H., Chang, C.-H., & Gean, P.-W. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0404-x · Cited by 139
“Infusion of amyloid fibrils significantly increased HDAC2 expression and its occupancy in the promoter region of Bdnf exon IV, resulting in histone H3 deacetylation and the suppression of BDNF expression [102, 103].”
BackgroundButyrate ameliorates quinolinic acid–induced cognitive decline in obesity models
Ge, X., Zheng, M., Hu, M., Fang, X., Geng, D., Liu, S., Wang, L., Zhang, J., Guan, L., Zheng, P., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci154612 · Cited by 130
“Furthermore, aberrant histone modifications at the BDNF promoters and abnormal BDNF levels have been linked to neurodegenerative disorders (18, 19), indicating that targeting the epigenetic regulation of BDNF would shed light on future therapeutic strategies.”
An Overview of the Epigenetic Modifications in the Brain under Normal and Pathological Conditions
Lossi, L., Castagna, C., & Merighi, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073881 · Cited by 112
“Impaired memory function Cerebral cortex Hippocampus BDNF [214] As mentioned, the dysregulation of histone modifications has been implicated in neurodegenerative diseases such as AD and PD, which display a typical old-age onset.”
BackgroundTang, X., Zhao, Y., Zhou, Z., Yan, J., Zhou, B., Chi, X., Luo, A., & Li, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9018624 · Cited by 84
“Recently, increasing attention has been paid to the epigenetic reprogramming of BDNF because this regulation mechanism takes part in activity-dependent synaptic function and the crosstalk of neuronal circuits [69, 70].”
Metadata
- Authors
- Chen, K.-W., & Chen, L.
- Affiliations
- National Tsing Hua University (TW)
- Corresponding author
- Chen, Linyi
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-03-06
- Volume
- 18
- Issue
- 3
- Pages
- 571
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5372587
- OpenAlex
- W2592608422
- Cited by
- 75
- References
- 66
- Citations by year
- 2026: 9 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 9 · 2021: 8 · 2020: 17 · 2019: 5 · 2018: 8 · 2017: 1
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Health Research Institutes, Taiwan (NHRI-EX106-10206NI)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- brain-derived neurotrophic factor, epigenetic regulation, histone modifications, promoter methylation, alternative promoters, transcriptional regulation, neurological disorders, brain development, ENCODE
- MeSH terms
- Animals, Histones, Humans, Protein Processing, Post-Translational, Gene Expression Regulation, Developmental, Brain-Derived Neurotrophic Factor, Neurodegenerative Diseases, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.